Mesolimbic dopamine and its neuromodulators in obesity and binge eating

CNS Spectrums

Volumn 20, Issue 6, 2015, Pages 574-583

  Naef, Lindsay ^a   Pitman, Kimberley A ^a   Borgland, Stephanie L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Diet induced obesity; hormones; mesolimbic dopamine; neuropeptides; striatum; ventral tegmental area

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; GHRELIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; LEPTIN; OREXIN;

BINGE EATING DISORDER; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; FEEDING BEHAVIOR; HUMAN; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BULIMIA; METABOLISM; VENTRAL TEGMENTUM;

ANIMALS; BULIMIA; CORPUS STRIATUM; DOPAMINE; HUMANS; OBESITY; VENTRAL TEGMENTAL AREA;

EID: 84949321649     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852915000693     Document Type: Review

References (127)

1. Beier KT, Steinberg EE, DeLoach KE, et al. Circuit architecture of VTA dopamine neurons revealed by systematic input-output mapping. Cell. 2015; 162(3): 622-634.
2. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A. 1988; 85(14): 5274-5278.
3. Call C, Walsh BT, Attia E. From DSM-IV to DSM-5: changes to eating disorder diagnoses. Curr Opin Psychiatry. 2013; 26(6): 532-536.
4. Woods SC, Seeley RJ, Rushing PA, D'Alessio D, Tso P. A controlled high-fat diet induces an obese syndrome in rats. J Nutr. 2003; 133(4): 1081-1087.
5. Stice E, Spoor S, Bohon C, Small DM. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science. 2008; 322(5900): 449-452.
6. Stice E, Spoor S, Bohon C, Veldhuizen MG, Small DM. Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study. J Abnorm Psychol. 2008; 117(4): 924-935.
7. Green E, Jacobson A, Haase L, Murphy C. Reduced nucleus accumbens and caudate nucleus activation to a pleasant taste is associated with obesity in older adults. Brain Res. 2011; 1386: 109-117.
8. Frank GKW, Reynolds JR, Shott ME, et al. Anorexia nervosa and obesity are associated with opposite brain reward response. Neuropsychopharmacology. 2012; 37(9): 2031-2046.
9. Martin LE, Holsen LM, Chambers RJ, et al. Neural mechanisms associated with food motivation in obese and healthy weight adults. Obesity (Silver Spring). 2010; 18(2): 254-260.
10. Rothemund Y, Preuschhof C, Bohner G, et al. Differential activation of the dorsal striatum by high-calorie visual food stimuli in obese individuals. Neuroimage. 2007; 37(2): 410-421.
11. Stoeckel LE, Kim J, Weller RE, Cox JE, Cook EW, Horwitz B. Effective connectivity of a reward network in obese women. Brain Res Bull. 2009; 79(6): 388-395.
12. Carnell S, Gibson C, Benson L, Ochner CN, Geliebter A. Neuroimaging and obesity: current knowledge and future directions. Obes Rev. 2012; 13(1): 43-56.
13. Li Y, South T, Han M, Chen J, Wang R, Huang X-F. High-fat diet decreases tyrosine hydroxylase mRNA expression irrespective of obesity susceptibility in mice. Brain Res. 2009; 1268: 181-189.
14. Ong ZY, Wanasuria AF, Lin MZP, Hiscock J, Muhlhausler BS. Chronic intake of a cafeteria diet and subsequent abstinence: sex-specific effects on gene expression in the mesolimbic reward system. Appetite. 2013; 65: 189-199.
15. Ahmed S, Kashem MA, Sarker R, Ahmed EU, Hargreaves GA, McGregor IS. Neuroadaptations in the striatal proteome of the rat following prolonged excessive sucrose intake. Neurochem Res. 2014; 39(5): 815-824.
16. Davis JF, Tracy AL, Schurdak JD, et al. Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat. Behav Neurosci. 2008; 122(6): 1257-1263.
17. Zhang C, Wei N-L, Wang Y, Wang X, Zhang J-G, Zhang K. Deep brain stimulation of the nucleus accumbens shell induces antiobesity effects in obese rats with alteration of dopamine neurotransmission. Neurosci Lett. 2015; 589: 1-6.
18. Hansen HH, Jensen MM, Overgaard A, Weikop P, Mikkelsen JD. Tesofensine induces appetite suppression and weight loss with reversal of low forebrain dopamine levels in the diet-induced obese rat. Pharmacol Biochem Behav. 2013; 110: 265-271.
19. Geiger BM, Haburcak M, Avena NM, Moyer MC, Hoebel BG, Pothos EN. Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity. Neuroscience. 2009; 159(4): 1193-1199.
20. Narayanaswami V, Thompson AC, Cassis LA, Bardo MT, Dwoskin LP. Diet-induced obesity: dopamine transporter function, impulsivity and motivation. Int J Obes (Lond). 2013; 37(8): 1095-1103.
21. Wang G-J, Geliebter A, Volkow ND, et al. Enhanced striatal dopamine release during food stimulation in binge eating disorder. Obesity (Silver Spring). 2011; 19(8): 1601-1608.
22. Rada P, Avena NM, Hoebel BG. Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell. Neuroscience. 2005; 134(3): 737-744.
23. Hajnal A, Norgren R. Repeated access to sucrose augments dopamine turnover in the nucleus accumbens. Neuroreport. 2002; 13(17): 2213-2216.
24. Carr KD. Chronic food restriction: enhancing effects on drug reward and striatal cell signaling. Physiol Behav. 2007; 91(5): 459-472.
25. Valdivia S, Cornejo MP, Reynaldo M, De Francesco PN, Perello M. Escalation in high fat intake in a binge eating model differentially engages dopamine neurons of the ventral tegmental area and requires ghrelin signaling. Psychoneuroendocrinology. 2015; 60: 206-216.
26. de Weijer BA, van de Giessen E, van Amelsvoort TA, et al. Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects. EJNMMI Res. 2011; 1(1): 37.
27. Haltia LT, Rinne JO, Merisaari H, et al. Effects of intravenous glucose on dopaminergic function in the human brain in vivo. Synapse. 2007; 61(9): 748-756.
28. Wang GJ, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet. 2001; 357(9253): 354-357.
29. Dunn JP, Kessler RM, Feurer ID, et al. Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity. Diabetes Care. 2012; 35(5): 1105-1111.
30. Kung HF, Pan S, Kung MP, et al. In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent. J Nucl Med. 1989; 30(1): 88-92.
31. Guo J, Simmons WK, Herscovitch P, Martin A, Hall KD. Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior. Mol Psychiatry. 2014; 19(10): 1078-1084.
32. Fossella J, Green AE, Fan J. Evaluation of a structural polymorphism in the ankyrin repeat and kinase domain containing (ANKK1) gene and the activation of executive attention networks. Cogn Affect Behav Neurosci. 2006; 6(1): 71-78.
33. Ritchie T, Noble EP. Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res. 2003; 28(1): 73-82.
34. Roth CL, Hinney A, Schur EA, Elfers CT, Reinehr T. Association analyses for dopamine receptor gene polymorphisms and weight status in a longitudinal analysis in obese children before and after lifestyle intervention. BMC Pediatr. 2013; 13: 197.
35. Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC. Relationships between the taqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol (Oxf). 2001; 55(5): 605-611.
36. Southon A, Walder K, Sanigorski AM, et al. The Taq IA and Ser311 Cys polymorphisms in the dopamine D2 receptor gene and obesity. Diabetes Nutr Metab. 2003; 16(1): 72-76.
37. Kaplan AS, Levitan RD, Yilmaz Z, Davis C, Tharmalingam S, Kennedy JL. A DRD4/BDNF gene-gene interaction associated with maximum BMI in women with bulimia nervosa. Int J Eat Disord. 2008; 41(1): 22-28.
38. Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci. 2010; 13(5): 635-641.
39. Hajnal A, Margas WM, Covasa M. Altered dopamine D2 receptor function and binding in obese OLETF rat. Brain Res Bull. 2008; 75(1): 70-76.
40. Colantuoni C, Schwenker J, McCarthy J, et al. Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport. 2001; 12(16): 3549-3552.
41. Huang X-F, Yu Y, Zavitsanou K, Han M, Storlien L. Differential expression of dopamine D2 and D4 receptor and tyrosine hydroxylase mRNA in mice prone, or resistant, to chronic high-fat diet-induced obesity. Brain Res Mol Brain Res. 2005; 135(1-2): 150-161.
42. South T, Huang X-F. High-fat diet exposure increases dopamine D2 receptor and decreases dopamine transporter receptor binding density in the nucleus accumbens and caudate putamen of mice. Neurochem Res. 2008; 33(3): 598-605.
43. Sharma S, Fulton S. Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry. Int J Obes (Lond). 2013; 37(3): 382-389.
44. van de Giessen E, la Fleur SE, de Bruin K, van den Brink W, Booij J. Free-choice and no-choice high-fat diets affect striatal dopamine D2/3 receptor availability, caloric intake, and adiposity. Obesity (Silver Spring). 2012; 20(8): 1738-1740.
45. van de Giessen E, la Fleur SE, Eggels L, de Bruin K, van den Brink W, Booij J. High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in dietinduced obesity. Int J Obes (Lond). 2013; 37(5): 754-757.
46. Davis CA, Levitan RD, Reid C, et al. Dopamine for "wanting" and opioids for "liking": a comparison of obese adults with and without binge eating. Obesity (Silver Spring). 2009; 17(6): 1220-1225.
47. Bello NT, Lucas LR, Hajnal A. Repeated sucrose access influences dopamine D2 receptor density in the striatum. Neuroreport. 2002; 13(12): 1575-1578.
48. Thomsen G, Ziebell M, Jensen PS, da Cuhna-Bang S, Knudsen GM, Pinborg LH. No correlation between body mass index and striatal dopamine transporter availability in healthy volunteers using SPECT and [123I]PE2I. Obesity (Silver Spring). 2013; 21(9): 1803-1806.
49. van de Giessen E, Hesse S, Caan MWA, et al. No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers. Neuroimage. 2013; 64: 61-67.
50. Chen PS, Yang YK, Yeh TL, et al. Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers-a SPECT study. Neuroimage. 2008; 40(1): 275-279.
51. Cone JJ, Chartoff EH, Potter DN, Ebner SR, Roitman MF. Prolonged high fat diet reduces dopamine reuptake without altering DAT gene expression. PloS One. 2013; 8(3): e58251.
52. Perry ML, Leinninger GM, Chen R, et al. Leptin promotes dopamine transporter and tyrosine hydroxylase activity in the nucleus accumbens of Sprague-Dawley rats. J Neurochem. 2010; 114(3): 666-674.
53. Mebel DM, Wong JCY, Dong YJ, Borgland SL. Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake. Eur J Neurosci. 2012; 36(3): 2336-2346.
54. Hryhorczuk C, Florea M, Rodaros D, et al. Dampened mesolimbic dopamine function and signaling by saturated but not monounsaturated dietary lipids. Neuropsychopharmacology. In press. DOI: 10.1038/npp.2015.207.
55. Shinohara M, Mizushima H, Hirano M, et al. Eating disorders with binge-eating behaviour are associated with the s allele of the 3′-UTR VNTR polymorphism of the dopamine transporter gene. J Psychiatry Neurosci. 2004; 29(2): 134-137.
56. Davis C, Levitan RD, Kaplan AS, et al. Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder. Neuropsychopharmacology. 2007; 32(10): 2199-2206.
57. Bello NT, Sweigart KL, Lakoski JM, Norgren R, Hajnal A. Restricted feeding with scheduled sucrose access results in an upregulation of the rat dopamine transporter. Am J Physiol Regul Integr Comp Physiol. 2003; 284(5): R1260-R1268.
58. Blum K, Sheridan PJ, Wood RC, et al. The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J R Soc Med. 1996; 89(7): 396-400.
59. Beeler JA, Faust RP, Turkson S, Ye H, Zhuang X. Low dopamine D2 receptor increases vulnerability to obesity via reduced physical activity not increased appetitive motivation. Biol Psychiatry. In press. DOI: 10.1016/j.biopsych.2015.07.009.
60. Liu S, Borgland SL. Regulation of the mesolimbic dopamine circuit by feeding peptides. Neuroscience. 2015; 289: 19-42.
61. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999; 402(6762): 656-660.
62. Cummings DE. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav. 2006; 89(1): 71-84.
63. Jerlhag E, Egecioglu E, Dickson SL, Douhan A, Svensson L, Engel JA. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol. 2007; 12(1): 6-16.
64. Naleid AM, Grace MK, Cummings DE, Levine AS. Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides. 2005; 26(11): 2274-2279.
65. Kawahara Y, Kawahara H, Kaneko F, et al. Peripherally administered ghrelin induces bimodal effects on the mesolimbic dopamine system depending on food-consumptive states. Neuroscience. 2009; 161(3): 855-864.
66. Skibicka KP, Hansson C, Alvarez-Crespo M, Friberg PA, Dickson SL. Ghrelin directly targets the ventral tegmental area to increase food motivation. Neuroscience. 2011; 180: 129-137.
67. Egecioglu E, Jerlhag E, Salomé N, et al. Ghrelin increases intake of rewarding food in rodents. Addict Biol. 2010; 15(3): 304-311.
68. Abizaid A, Liu Z-W, Andrews ZB, et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest. 2006; 116(12): 3229-3239.
69. Quarta D, Di Francesco C, Melotto S, Mangiarini L, Heidbreder C, Hedou G. Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens. Neurochem Int. 2009; 54(2): 89-94.
70. Cone JJ, Roitman JD, Roitman MF. Ghrelin regulates phasic dopamine and nucleus accumbens signaling evoked by foodpredictive stimuli. J Neurochem. 2015; 133(6): 844-856.
71. Moesgaard SG, Ahrén B, Carr RD, Gram DX, Brand CL, Sundler F. Effects of high-fat feeding and fasting on ghrelin expression in the mouse stomach. Regul Pept. 2004; 120(1-3): 261-267.
72. Perreault M, Istrate N, Wang L, Nichols AJ, Tozzo E, Stricker-Krongrad A. Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss. Int J Obes (Lond). 2004; 28(7): 879-885.
73. Lindqvist A, de la Cour CD, Stegmark A, Håkanson R, Erlanson-Albertsson C. Overeating of palatable food is associated with blunted leptin and ghrelin responses. Regul Pept. 2005; 130(3): 123-132.
74. Williams DL, Grill HJ, Cummings DE, Kaplan JM. Overfeedinginduced weight gain suppresses plasma ghrelin levels in rats. J Endocrinol Invest. 2006; 29(10): 863-868.
75. Murray S, Tulloch A, Gold MS, Avena NM. Hormonal and neural mechanisms of food reward, eating behaviour and obesity. Nat Rev Endocrinol. 2014; 10(9): 540-552.
76. van Zessen R, van der Plasse G, Adan RA. Contribution of the mesolimbic dopamine system in mediating the effects of leptin and ghrelin on feeding. Proc Nutr Soc. 2012; 71(4): 435-445.
77. Mahler SV, Moorman DE, Smith RJ, James MH, Aston-Jones G. Motivational activation: a unifying hypothesis of orexin/hypocretin function. Nat Neurosci. 2014; 17(10): 1298-1303.
78. Perello M, Sakata I, Birnbaum S, et al. Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biol Psychiatry. 2010; 67(9): 880-886.
79. Cone JJ, McCutcheon JE, Roitman MF. Ghrelin acts as an interface between physiological state and phasic dopamine signaling. J Neurosci. 2014; 34(14): 4905-4913.
80. Thompson JL, Borgland SL. A role for hypocretin/orexin in motivation. Behav Brain Res. 2011; 217(2): 446-453.
81. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci. 2003; 23(1): 7-11.
82. Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron. 2006; 49(4): 589-601.
83. Vittoz NM, Berridge CW. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology. 2006; 31(2): 384-395.
84. España RA, Oleson EB, Locke JL, Brookshire BR, Roberts DCS, Jones SR. The hypocretin-orexin system regulates cocaine selfadministration via actions on the mesolimbic dopamine system. Eur J Neurosci. 2010; 31(2): 336-348.
85. Borgland SL, Chang S-J, Bowers MS, et al. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci. 2009; 29(36): 11215-11225.
86. Teske JA, Levine AS, Kuskowski M, Levine JA, Kotz CM. Elevated hypothalamic orexin signaling, sensitivity to orexin A, and spontaneous physical activity in obesity-resistant rats. Am J Physiol Regul Integr Comp Physiol. 2006; 291(4): R889-R899.
87. Funato H, Tsai AL, Willie JT, et al. Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab. 2009; 9(1): 64-76.
88. Nobunaga M, Obukuro K, Kurauchi Y, et al. High fat diet induces specific pathological changes in hypothalamic orexin neurons in mice. Neurochem Int. 2014; 78: 61-66.
89. Zhu Y, Yamanaka A, Kunii K, Tsujino N, Goto K, Sakurai T. Orexin-mediated feeding behavior involves both leptin-sensitive and -insensitive pathways. Physiol Behav. 2002; 77(2-3): 251-257.
90. Horvath TL, Gao X-B. Input organization and plasticity of hypocretin neurons: possible clues to obesity's association with insomnia. Cell Metab. 2005; 1(4): 279-286.
91. Cristino L, Busetto G, Imperatore R, et al. Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons. Proc Natl Acad Sci U S A. 2013; 110(24): E2229-E2238.
92. Teegarden SL, Nestler EJ, Bale TL. Delta FosB-mediated alterations in dopamine signaling are normalized by a palatable high-fat diet. Biol Psychiatry. 2008; 64(11): 941-950.
93. Valdivia S, Patrone A, Reynaldo M, Perello M. Acute high fat diet consumption activates the mesolimbic circuit and requires orexin signaling in a mouse model. PloS One. 2014; 9(1): e87478.
94. Ahima RS, Flier JS. Leptin. Annu Rev Physiol. 2000; 62: 413-437.
95. El-Haschimi K, Pierroz DD, Hileman SM, Bjørbaek C, Flier JS. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest. 2000; 105(12): 1827-1832.
96. Trinko R, Gan G, Gao X-B, Sears RM, Guarnieri DJ, DiLeone RJ. Erk1/2 mediates leptin receptor signaling in the ventral tegmental area. PloS One. 2011; 6(11): e27180.
97. Hommel JD, Trinko R, Sears RM, et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron. 2006; 51(6): 801-810.
98. Thompson JL, Borgland SL. Presynaptic leptin action suppresses excitatory synaptic transmission onto ventral tegmental area dopamine neurons. Biol Psychiatry. 2013; 73(9): 860-868.
99. Krügel U, Schraft T, Kittner H, Kiess W, Illes P. Basal and feedingevoked dopamine release in the rat nucleus accumbens is depressed by leptin. Eur J Pharmacol. 2003; 482(1-3): 185-187.
100. van der Plasse G, van Zessen R, Luijendijk MCM, et al. Modulation of cue-induced firing of ventral tegmental area dopamine neurons by leptin and ghrelin. Int J Obes (Lond). In press. DOI: 10.1038/ijo.2015.131.
101. Fulton S, Pissios P, Manchon RP, et al. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron. 2006; 51(6): 811-822.
102. Roseberry AG, Painter T, Mark GP, Williams JT. Decreased vesicular somatodendritic dopamine stores in leptindeficient mice. J Neurosci. 2007; 27(26): 7021-7027.
103. Matheny M, Shapiro A, Tümer N, Scarpace PJ. Region-specific diet-induced and leptin-induced cellular leptin resistance includes the ventral tegmental area in rats. Neuropharmacology. 2011; 60 (2-3): 480-487.
104. Bruijnzeel AW, Qi X, Corrie LW. Anorexic effects of intra-VTA leptin are similar in low-fat and high-fat-fed rats but attenuated in a subgroup of high-fat-fed obese rats. Pharmacol Biochem Behav. 2013; 103(3): 573-581.
105. van den Heuvel JK, Eggels L, Fliers E, Kalsbeek A, Adan RAH, la Fleur SE. Differential modulation of arcuate nucleus and mesolimbic gene expression levels by central leptin in rats on shortterm high-fat high-sugar diet. PloS One. 2014; 9(1): e87729 doi:10.1371/journal.pone.0087729.
106. Powley TL. The ventromedial hypothalamic syndrome, satiety, and a cephalic phase hypothesis. Psychol Rev. 1977; 84(1): 89-126.
107. McGowan MK, Andrews KM, Grossman SP. Chronic intrahypothalamic infusions of insulin or insulin antibodies alter body weight and food intake in the rat. Physiol Behav. 1992; 51(4): 753-766.
108. Figlewicz DP, Evans SB, Murphy J, Hoen M, Baskin DG. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res. 2003; 964(1): 107-115.
109. Pardini AW, Nguyen HT, Figlewicz DP, et al. Distribution of insulin receptor substrate-2 in brain areas involved in energy homeostasis. Brain Res. 2006; 1112(1): 169-178.
110. Liu S, Labouèbe G, Karunakaran S, Clee SM, Borgland SL. Effect of insulin on excitatory synaptic transmission onto dopamine neurons of the ventral tegmental area in a mouse model of hyperinsulinemia. Nutr Diabetes. 2013; 3: e97.
111. Labouèbe G, Liu S, Dias C, et al. Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids. Nat Neurosci. 2013; 16(3): 300-308.
112. Bruijnzeel AW, Corrie LW, Rogers JA, Yamada H. Effects of insulin and leptin in the ventral tegmental area and arcuate hypothalamic nucleus on food intake and brain reward function in female rats. Behav Brain Res. 2011; 219(2): 254-264.
113. Könner AC, Hess S, Tovar S, et al. Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis. Cell Metab. 2011; 13(6): 720-728.
114. Portella AK, Silveira PP, Laureano DP, et al. Litter size reduction alters insulin signaling in the ventral tegmental area and influences dopamine-related behaviors in adult rats. Behav Brain Res. 2015; 278: 66-73.
115. Steculorum SM, Solas M, Brüning JC. The paradox of neuronal insulin action and resistance in the development of agingassociated diseases. Alzheimers Dement. 2014; 10(1 Suppl): S3-S11.
116. Rinaman L. Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure. Brain Res. 2010; 1350: 18-34.
117. Merchenthaler I, Lane M, Shughrue P. Distribution of pre-proglucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol. 1999; 403(2): 261-280.
118. Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience. 1997; 77(1): 257-270.
119. Alhadeff AL, Rupprecht LE, Hayes MR. GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology. 2012; 153(2): 647-658.
120. Campos RV, Lee YC, Drucker DJ. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagonlike peptide-1 in the mouse. Endocrinology. 1994; 134(5): 2156-2164.
121. Mietlicki-Baase EG, Ortinski PI, Rupprecht LE, et al. The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors. Am J Physiol Endocrinol Metab. 2013; 305(11): E1367-E1374.
122. Wang X-F, Liu J-J, Xia J, Liu J, Mirabella V, Pang ZP. Endogenous glucagon-like peptide-1 suppresses high-fat food intake by reducing synaptic drive onto mesolimbic dopamine neurons. Cell Rep. 2015; 12(5): 726-733.
123. Heppner KM, Perez-Tilve D. GLP-1 based therapeutics: simultaneously combating T2DM and obesity. Front Neurosci. 2015; 9: 92.
124. Chen H, Simar D, Morris MJ. Maternal obesity impairs brain glucose metabolism and neural response to hyperglycemia in male rat offspring. J Neurochem. 2014; 129(2): 297-303.
125. Chan YL, Saad S, Simar D, et al. Short term exendin-4 treatment reduces markers of metabolic disorders in female offspring of obese rat dams. Int J Dev Neurosci. 2015; 46: 67-75.
126. Cao X, Xu P, Oyola MG, et al. Estrogens stimulate serotonin neurons to inhibit binge-like eating in mice. J Clin Invest. 2014; 124(10): 4351-4362.
127. Robert SA, Rohana AG, Shah SA, Chinna K, Wan Mohamud WN, Kamaruddin NA. Improvement in binge eating in non-diabetic obese individuals after 3 months of treatment with liraglutide-a pilot study. Obes Res Clin Pract. 2015; 9(3): 301-304.